Product ID: SQMIG35A2819
Report ID:
SQMIG35A2819 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|
Tables:
67 |
Figures:
65
North America asserts its dominance in the cardiopulmonary exercise testing (CPET) market, mainly due to the rising incidence of cardiopulmonary diseases in the region. Conditions such as congestive heart failure, cardiomyopathy, ischemic heart disease, dyspnea, and myocardial imbalance in CPET contribute to increased. Increasing awareness among physicians of the benefits of cardiopulmonary exercise testing is fueling further acceptance.
Asia Pacific ranks as the largest market for cardiopulmonary exercise testing, driven by a combination of factors. Increasing disposable income in the region helps to bring in more individuals to the health care system for preventive measures such as cardiopulmonary fitness testing. As well as a greater focus on services, the region benefits from lower manufacturing costs for medical devices and lower labor costs overall.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35A2819